- Home
- NRGV vs KURA Comparison
NRGV vs KURA Comparison
Compare NRGV & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRGV
- KURA
- Stock Information
- Founded
- NRGV 2017
- KURA 2014
- Country
- NRGV United States
- KURA United States
- Employees
- NRGV N/A
- KURA N/A
- Industry
- NRGV Industrial Machinery/Components
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NRGV Miscellaneous
- KURA Health Care
- Exchange
- NRGV Nasdaq
- KURA Nasdaq
- Market Cap
- NRGV 629.6M
- KURA 713.5M
- IPO Year
- NRGV N/A
- KURA N/A
- Fundamental
- Price
- NRGV $3.58
- KURA $10.19
- Analyst Decision
- NRGV Buy
- KURA Strong Buy
- Analyst Count
- NRGV 3
- KURA 13
- Target Price
- NRGV $1.83
- KURA $25.00
- AVG Volume (30 Days)
- NRGV 2.7M
- KURA 2.1M
- Earning Date
- NRGV 11-10-2025
- KURA 11-04-2025
- Dividend Yield
- NRGV N/A
- KURA N/A
- EPS Growth
- NRGV N/A
- KURA N/A
- EPS
- NRGV N/A
- KURA N/A
- Revenue
- NRGV $51,716,000.00
- KURA $104,029,000.00
- Revenue This Year
- NRGV $314.68
- KURA $68.63
- Revenue Next Year
- NRGV $38.97
- KURA $141.59
- P/E Ratio
- NRGV N/A
- KURA N/A
- Revenue Growth
- NRGV N/A
- KURA N/A
- 52 Week Low
- NRGV $0.60
- KURA $5.41
- 52 Week High
- NRGV $4.56
- KURA $19.73
- Technical
- Relative Strength Index (RSI)
- NRGV 56.05
- KURA 55.19
- Support Level
- NRGV $3.15
- KURA $8.83
- Resistance Level
- NRGV $3.71
- KURA $10.46
- Average True Range (ATR)
- NRGV 0.33
- KURA 0.77
- MACD
- NRGV -0.06
- KURA -0.07
- Stochastic Oscillator
- NRGV 56.61
- KURA 58.88
About NRGV Energy Vault Holdings Inc.
Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.